Skip to Content
Merck
CN

GF75301668

Samarium

foil, not light tested, 50x50mm, thickness 0.025mm, as rolled, 99%

Synonym(s):

Samarium, SM000200

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
Sm
CAS Number:
Molecular Weight:
150.36
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12141612
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Samarium, foil, not light tested, 50x50mm, thickness 0.025mm, as rolled, 99%

InChI

1S/Sm

SMILES string

[Sm]

InChI key

KZUNJOHGWZRPMI-UHFFFAOYSA-N

assay

99%

form

foil

manufacturer/tradename

Goodfellow 753-016-68

resistivity

91.4 μΩ-cm, 0°C

size × thickness

50 x 50 mm × 0.025 mm

bp

1794 °C (lit.)

mp

1074 °C (lit.)

density

7.47 g/mL at 25 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

pictograms

Flame

signalword

Warning

hcodes

Hazard Classifications

Water-react 3

Storage Class

4.3 - Hazardous materials which set free flammable gases upon contact with water

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Pete Anderson et al.
Expert review of anticancer therapy, 7(11), 1517-1527 (2007-11-21)
Radiation therapy can be an effective means to treat bone metastases, which occur in more than 50% of cancer patients. (153)Samarium lexidronam ((153)Sm-EDTMP; Quadramet, Cytogen) is a radiopharmaceutical designed for deposition into bone metastases. Bone scans can identify patients that
Michal Szostak et al.
Chemical communications (Cambridge, England), 48(3), 330-346 (2011-09-01)
Samarium diiodide (SmI(2)) is one of the most important reductive electron transfer reagents available in the laboratory. Key to the popularity of SmI(2) is the ability of additives and co-solvents to tune the properties of the reagent. Over the last
Samarium(II)-iodide-mediated cyclizations in natural product synthesis.
David J Edmonds et al.
Chemical reviews, 104(7), 3371-3404 (2004-07-15)
Pete Anderson
Expert opinion on pharmacotherapy, 7(11), 1475-1486 (2006-07-25)
Samarium-153 lexidronam (153Sm-EDTMP) is FDA approved for painful osteoblastic bone metastases that image on bone scan. 153Sm-EDTMP decay has a therapeutic beta-emission and a gamma-photon for bone scan imaging. Monitoring of osteosarcoma radiation treatment effectiveness was performed with bone, CT
Y Kamochi et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 120(3), 245-255 (2000-03-21)
This review deals with the rapid reduction of a variety of organic functionalities, including a new selective reduction of carboxylic acid, with samarium diiodide in the presence of additives under mild conditions. The single electron donor ability of samarium diiodide

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service